- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07731568
Efficacy and Underlying Mechanisms of Group Natural Psychotherapy for Anxiety Symptoms
Efficacy and Underlying Mechanisms of Group Natural Psychotherapy for Anxiety Symptoms In Chinese University Students
The goal of this clinical trial is to learn if Natural Psychotherapy(NPT) works to treat anxiety symptoms in university students. It will also learn about the efficacy of Natural Psychotherapy in comparison to CBT.
The main questions are: Does online group Natural Psychotherapy lower the participants' anxiety symptoms? Is there any difference between NPT and CBT? Researchers will compare online group Natural Psychotherapy to online group Cognitive Behavioral Therapy(CBT) to see if Natural Psychotherapy works better to lower anxiety symptoms.
Participants will:
Attend online groupNPT or group CBT once a week for 4 weeks; Complete online questionnaires before the intervention, after the first week, after four weeks and after eight weeks.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Professor Zhang
- Phone Number: +86 18513299860
- Email: zhangxy99@mail.tsinghua.edu.cn
Study Locations
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, China, 100084
- Recruiting
- Tsinghua University
-
Contact:
- Professor Zhang
- Phone Number: +86 18513299860
- Email: zhangxy99@mail.tsinghua.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Voluntarily signed the informed consent form
- Generalized Anxiety Disorder-7 (GAD-7) total score≥4
- Chinese
- Aged 18-30 years, currently enrolled as an undergraduate or postgraduate student.
Exclusion Criteria:
- Severe depression or high risk of suicide
- History of substance abuse, drug dependence, or psychotic disorders
- Severe neurological diseases, severe somatic illnesses, or other conditions unsuitable for physical labor or physical activities
- History of electroconvulsive therapy (ECT) within the past 6 months, or currently undergoing other pharmacological or systematic psychological treatments.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group Natural Psychotherapy
NPT is a novel approach integrating Japanese Morita therapy and traditional Chinese culture. It proposes three core principles for treating anxiety.
|
NPT's principle is fundamentally about fostering a proactive mindset.
The participants are encouraged to actively seek out and engage with life's inherent challenges and discomforts as a path to growth.
The emphasis is on cultivating courage and initiative as a characterological trait, transforming the individual's relationship with fear itself, rather than solely habituating to specific triggers.
This represents a shift from a disorder-specific protocol to a life-oriented philosophy.
|
|
Active Comparator: Group Cognitive Behavioral Therapy
A 4-week structured online group CBT intervention will be delivered weekly (90 mins per session) via an online meeting app.
Homework compliance (e.g., self-monitoring tables and behavioral logs) is required weekly. |
CBT-1 is a 4-week structured online group cognitive behavioral therapy program tailored for college students with subclinical anxiety.
The protocol systematically guides participants to deconstruct anxiety into an interconnected loop of situations, automatic thoughts, and behaviors.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Generalized Anxiety Disorder Assessment (GAD-7)
Time Frame: Baseline, After 1 Week, After 4 weeks, After 8 weeks
|
The GAD-7 is a 7-item, self-reported Likert scale used to assess the severity of participants' anxiety symptoms over the past two weeks.
Each item is scored from 0 (not at all) to 3 (nearly every day), yielding a total score ranging from 0 to 21, with higher scores indicating greater anxiety severity.
The primary endpoint will evaluate the mean change in GAD-7 scores from baseline (Pre-intervention) to post-intervention (Week 4) to determine the efficacy of the intervention.
|
Baseline, After 1 Week, After 4 weeks, After 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Beck Depression Inventory(BDI)
Time Frame: Baseline, After 1 week, After 4 weeks, After 8 weeks
|
The Beck Depression Inventory (BDI) is a 21-item, self-reported Likert scale used to measure the severity of depressive symptoms.
Each item is scored on a 4-point scale ranging from 0 to 3. The total score is calculated by summing the scores of all 21 items, yielding a total score range from 0 to 63.
Higher total scores indicate more severe depressive symptoms.
|
Baseline, After 1 week, After 4 weeks, After 8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insomnia Severity Index (ISI)
Time Frame: Baseline, After 1 week, After 4 weeks, After 8 weeks
|
The Insomnia Severity Index (ISI) is a 7-item self-report instrument assessing the nature, severity, and impact of insomnia over the past two weeks.
Each item is rated on a 5-point Likert scale from 0 to 4. The total score is obtained by summing all 7 items, ranging from 0 to 28.
Higher total scores reflect a higher severity of insomnia symptoms and greater perceived impairment.
|
Baseline, After 1 week, After 4 weeks, After 8 weeks
|
|
State-Trait Anxiety Inventory - State Anxiety (STAI-S)
Time Frame: Baseline, After 4 weeks, After 8 weeks
|
The State-Trait Anxiety Inventory for State Anxiety (STAI-S) is a 20-item self-report scale evaluating a person's current, transient state of anxiety (how they feel "right now").
Items are scored on a 4-point Likert scale from 1 (not at all) to 4 (very much so).
After reverse-scoring appropriate items, the total score ranges from 20 to 80. Higher total scores indicate greater levels of current, situational anxiety.
|
Baseline, After 4 weeks, After 8 weeks
|
|
State-Trait Anxiety Inventory - Trait Anxiety (STAI-T)
Time Frame: Baseline, After 4 weeks, After 8 weeks
|
The State-Trait Anxiety Inventory for Trait Anxiety (STAI-T) is a 20-item self-report scale assessing relatively stable, long-term personality traits related to anxiety proneness (how they "generally" feel).
Items are scored on a 4-point Likert scale from 1 (almost never) to 4 (almost always).
After reverse-scoring appropriate items, the total score ranges from 20 to 80. Higher total scores indicate a greater propensity to experience anxiety as a personality trait.
|
Baseline, After 4 weeks, After 8 weeks
|
|
Intolerance of Uncertainty Scale (IUS-12)
Time Frame: Baseline, After 4 weeks, After 8 weeks
|
The Intolerance of Uncertainty Scale (IUS-12) is a 12-item self-report scale measuring negative emotional, cognitive, and behavioral reactions to uncertainty.
Each item is rated on a 5-point Likert scale from 1 (not at all characteristic of me) to 5 (entirely characteristic of me).
The total score is computed by summing all items, ranging from 12 to 60. Higher total scores represent a lower tolerance for uncertainty and greater anxiety regarding future events.
|
Baseline, After 4 weeks, After 8 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ThuPsy-202601
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety Symptoms
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston University; Johns Hopkins... and other collaboratorsCompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety DisordersUnited States
-
UCLH/UCL Joint Research OfficeMedical Research Council; Camden and Islington NHS Trust; Central and North West...RecruitingAnxiety Disorders | Anxiety | Anxiety Depression | CBT | Anxiety Disorders and Symptoms | Anxiety Generalized | Generalised Anxiety Disorder | Anxiety Disorder; Mixed With Depression (Mild) | Anxiety Disorder GeneralizedUnited Kingdom
-
University of AlcalaCompletedAnxiety | Depressive Symptoms | Anxiety Symptoms | Subthreshold DepressionSpain
-
Aveiro UniversityFoundation for Science and TechnologyNot yet recruitingAnxiety Disorders | Anxiety SymptomsPortugal
-
International Association Psychosomatics And Health...RecruitingAnxiety | Anxiety DepressionUkraine
-
Tribhuvan University Teaching Hospital, Institute...CompletedAnxiety Disorder/Anxiety StateNepal
-
Linkoeping UniversityActive, not recruitingDepressive Symptoms | Anxiety SymptomsBrazil
-
Babes-Bolyai UniversityRecruitingDepression | Anxiety | Death AnxietyRomania
-
YAU Suk Yu SonataCompletedHealthy | Anxiety Symptoms | Depression SymptomsHong Kong
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
Clinical Trials on Natural Psychotherapy
-
Xiang Yang ZhangRecruitingObsessive-Compulsive DisorderChina
-
Beijing HuiLongGuan HospitalInstitute of Psychology, Chinese Academy of Sciences; Fourth People's Hospital...Active, not recruitingObsessive - Compulsive DisorderChina
-
Beijing HuiLongGuan HospitalCompletedObsessive-Compulsive DisorderChina
-
Beijing HuiLongGuan HospitalActive, not recruiting
-
Sprim Advanced Life SciencesArtsana S.p.a.CompletedFeeding Behavior
-
Wenxiang WangShanghai Houchao Biotechnology Co., LtdUnknownNon-small Cell Lung CancerChina
-
Hampton VA Medical CenterCompletedPersonality Disorders | Depression | Bipolar Disorder | Substance Use Disorders | PsychosisUnited States
-
Acibadem UniversityUnknownInfertility, FemaleTurkey
-
Alcon ResearchCompleted
-
Alpha - Bio Tec Ltd.Unknown